AngioDynamics | ANGO - Cash And Equivalent


AngioDynamics reported $44.76M in Cash and Equivalent for its fiscal quarter ending in February of 2025.





Cash And Equivalent Change Date
AngioDynamics USD 44.76M 9.33M Feb/2025
AtriCure USD 147.86M 30.07M Sep/2025
Boston Scientific USD 1.28B 741M Sep/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
ICU Medical USD 300.02M 10.32M Jun/2025
Inogen USD 106.48M 2.79M Sep/2025
J&J USD 19.71B 1.48B Dec/2025
Medtronic USD 1.28B 9M Sep/2025
Merit Medical Systems USD 392.46M 50.64M Sep/2025
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 62.86M 2.75M Sep/2025
Smiths GBP 392M 1.32B Dec/2024
Surmodics USD 36.11M 11.81M Sep/2024
Tandem Diabetes Care USD 91.95M 27.83M Sep/2025
Teleflex USD 354M 100.3M Sep/2025
Terumo JPY 204.29B 17.58B Jun/2025
Trinity Biotech USD 1.34M 3.83M Sep/2025